About this item:

49 Views | 26 Downloads

Author Notes:

Arjee Javellana Restar, Department of Epidemiology, University of Washington School of Public Health, 3980 15th Ave NE, Seattle, WA 98105, USA. Email: restar@uw.edu; arjee.restar2gmail.com

AJR, MIQ, JW, AA, ANB, DO and OS were involved in the conceptualization of this paper. AJR, DO and OS designed the analysis for this paper. AJR conducted the data analysis. AJR, MIQ, ANB, JG and OS analysed the data. AJR and MIQ wrote the paper. AJR, MIQ, JW, AA, JG, ANB, OG, DDF, SCU, JN, DO and OS have read, reviewed, edited and approved the final version of this manuscript.

We are grateful for all of the Filipina transfeminine participants who took part in this study.

The authors declare that they have no competing interests.

Subjects:

Research Funding:

This study was supported by the following sponsors: National Institute on Drug Abuse (R36DA048682), the Fogarty International Center (D43TW010565), Providence/Boston Center for AIDS Research (P30AI042853) and the National Institute of Mental Health (R21TW012010). Dr. Restar is a Robert Wood Johnson Foundation Health Policy Research Scholar and a Public Policy Fellow at amFAR, the Foundation for AIDS Research. Drs. Restar, Flores and Wickersham are supported by the Research Education Institute for Diverse Scholars (REIDS), funded by the National Institute of Mental Health (R25MH087217).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Immunology
  • Infectious Diseases
  • HIV
  • PrEP
  • transfeminine
  • transgender
  • Philippines
  • implementation
  • TRANSGENDER WOMEN
  • ACCEPTABILITY
  • FACILITATORS
  • BARRIERS
  • MEN
  • SEX

Predictors of PrEP awareness, PrEP discussion and interest in long-acting injectable PrEP among Filipina transfeminine adults

Show all authors Show less authors

Tools:

Journal Title:

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY

Volume:

Volume 26, Number 6

Publisher:

, Pages e26080-e26080

Type of Work:

Article | Final Publisher PDF

Abstract:

Introduction: Transfeminine adults are impacted by the HIV epidemic in the Philippines, and newly approved modalities of pre-exposure prophylaxis (PrEP), including long-acting injectable (LAI-PrEP), could be beneficial for this group. To inform implementation, we analysed PrEP awareness, discussion and interest in taking LAI-PrEP among Filipina transfeminine adults. Methods: We utilized secondary data from the #ParaSaAtin survey that sampled Filipina transfeminine adults (n = 139) and conducted a series of multivariable logistic regressions with lasso selection to explore factors independently associated with PrEP outcomes, including awareness, discussion with trans friends and interest in LAI-PrEP. Results: Overall, 53% of Filipina transfeminine respondents were aware of PrEP, 39% had discussed PrEP with their trans friends and 73% were interested in LAI-PrEP. PrEP awareness was associated with being non-Catholic (p = 0.017), having previously been HIV tested (p = 0.023), discussing HIV services with a provider (p<0.001) and having high HIV knowledge (p = 0.021). Discussing PrEP with friends was associated with older age (p = 0.040), having experienced healthcare discrimination due to transgender identity (p = 0.044), having HIV tested (p = 0.001) and having discussed HIV services with a provider (p < 0.001). Very interested in LAI-PrEP was associated with living in Central Visayas (p = 0.045), having discussed HIV services with a provider (p = 0.001) and having discussed HIV services with a sexual partner (p = 0.008). Conclusions: Implementing LAI-PrEP in the Philippines requires addressing systemic improvements across personal, interpersonal, social and structural levels in healthcare access, including efforts to create healthcare settings and environments with providers who are trained and competent in transgender health and can address the social and structural drivers of trans health inequities, including HIV and barriers to LAI-PrEP.

Copyright information:

© 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote